PofoliaShared via Pofolia

CAAI Transactions on Intelligence Technology· 2026Q1

A Validation Method for the Enhanced Fuzzy Min‐Max Neural Network With Application to Heart Disease Data Classification

Mohammed Falah Mohammed, Osama Nayel Al Sayaydeh, Taha H. Rassem, Chee Peng Lim

Short summary

A novel Enhanced Fuzzy Min-Max (EFMM) neural network with a refined contraction procedure and weighted validation method achieves 82.11% accuracy in heart disease classification, outperforming existing models.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Introduced a new EFMM neural network with refined contraction and weighted validation for heart disease detection.
  • Achieved 82.11% accuracy with 5-fold cross-validation and 81.56% with 10-fold cross-validation on heart disease datasets.
  • Outperformed original FMM, other FMM variants (GFMM, IOL-GFMM, etc.), and non-FMM classifiers (J48, MLP, IBK, AdaBoost).
  • Demonstrated superior accuracy, sensitivity, and specificity on real-world heart disease data compared to FMM and EFMM.

AI-generated from the title and abstract; the full text is not read.

Abstract

ABSTRACT This study investigates early detection of heart diseases using a new Enhanced Fuzzy Min‐Max (EFMM) neural network. Two key modifications are introduced: a refined EFMM contraction procedure during the learning phase to reduce data distortion and information loss, and a new weighted validation method to optimise hyperbox selection and improve prediction accuracy. The proposed model is evaluated with heart disease data sets subject to varying expansion constraints, training data sizes, and cross‐validation settings. The results indicate that the proposed EFMM model consistently outperforms other models, including the original Fuzzy Min‐Max (FMM), EFMM, and non‐FMM classifiers such as J48, MLP, IBK, AdaBoost, and others. The test accuracy rates achieve 82.11% with 5‐fold cross‐validation and 81.56% with 10‐fold cross‐validation. Compared with other FMM variants, the proposed model achieves 80.26% accuracy, surpassing GFMM, IOL‐GFMM, Kn‐EFMM, and RFMM models. Using real‐world heart disease data, the proposed model outperforms FMM and EFMM in terms of accuracy, sensitivity, and specificity. Statistical test results indicate the effectiveness of the proposed model in performance statistically, as compared with those FMM, EFMM, and other classifiers. The improved EFMM model is generic and applicable not only to heart disease diagnosis but also to other general data classification tasks.

The authors' abstract, as published at the source. CAAI Transactions on Intelligence Technology, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Health Information Management

Health Information ManagementHealth Professions